已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Long-term results of endovascular treatment for arteriovenous dialysis access thrombosis in 143 patients: A single center experience

医学 动静脉瘘 血栓形成 外科 血液透析 单中心 透析 动静脉畸形 人口 血管内治疗 放射科 动脉瘤 环境卫生
作者
Yunus Yılmazsoy,Umut Özyer
出处
期刊:Journal of Vascular Access [SAGE]
卷期号:20 (5): 545-552 被引量:8
标识
DOI:10.1177/1129729819865808
摘要

This study aimed to determine the long-term patency duration and rate of thrombosis of autologous arteriovenous fistulas and synthetic grafts treated with endovascular methods in a large patient population.A total of 144 arteriovenous accesses (37 radiocephalic, 51 brachiobasilic, 41 brachiocephalic, and 15 femorofemoral) from 143 patients were included in the study. A total of 304 endovascular thrombolytic treatment procedures were performed for 94 (65%) arteriovenous fistula and 50 (35%) arteriovenous graft accesses.The procedural technical success rate was 98.7%. The mean follow-up duration was 32.5 (range, 3-132) months. The primary patency rates for arteriovenous fistulas and arteriovenous grafts were 78% and 78% at 6 months, 66% and 63% at 1 year, and 45% and 0% at 36 months, respectively. The assisted primary patency rates for arteriovenous fistulas and arteriovenous grafts were 82% and 84% at 6 months, 71% and 69% at 1 year, 51% and 29% at 36 months, and 30% and 1% at 60 months, respectively. The secondary patency rates for arteriovenous fistulas and arteriovenous grafts were 94% and 93% at 6 months, 85% and 85% at 1 year, 58% and 59% at 36 months, and 47% and 48% at 60 months, respectively.Although the primary patency durations for arteriovenous fistulas were better after endovascular thrombolytic treatment than those for arteriovenous grafts, the long-term outcomes of assisted primary and secondary patency durations after repeated procedures were similar for both types of arteriovenous accesses.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小树一一发布了新的文献求助10
3秒前
赵毛毛完成签到,获得积分10
3秒前
tiptip应助科研通管家采纳,获得10
3秒前
3秒前
顾矜应助科研通管家采纳,获得10
3秒前
留胡子的邑完成签到,获得积分10
4秒前
5秒前
6秒前
dsfiugelau完成签到,获得积分10
8秒前
英勇的梨愁完成签到 ,获得积分10
13秒前
所所应助大力的图图采纳,获得10
13秒前
14秒前
KamilahKupps发布了新的文献求助10
15秒前
典希子完成签到 ,获得积分10
16秒前
brwen发布了新的文献求助10
17秒前
Amelk发布了新的文献求助10
19秒前
传奇3应助秀丽茹妖采纳,获得10
21秒前
23秒前
852应助科研通管家采纳,获得10
23秒前
tiptip应助科研通管家采纳,获得10
23秒前
小马甲应助科研通管家采纳,获得20
23秒前
Hello应助科研通管家采纳,获得10
23秒前
李健的小迷弟应助CyberLee采纳,获得10
24秒前
赘婿应助无语的不可采纳,获得100
24秒前
25秒前
云中漫步关注了科研通微信公众号
29秒前
科研通AI6.2应助TszPok采纳,获得10
31秒前
jiangmi完成签到,获得积分10
31秒前
hflion完成签到,获得积分10
32秒前
NexusExplorer应助emo的哈哈哈采纳,获得10
33秒前
南宫初柒完成签到 ,获得积分10
37秒前
久等雨归发布了新的文献求助10
37秒前
38秒前
38秒前
42秒前
无语的不可完成签到,获得积分10
42秒前
染东完成签到,获得积分10
43秒前
大模型应助务实盼波采纳,获得10
44秒前
Chen完成签到 ,获得积分10
44秒前
44秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
First commercial application of ELCRES™ HTV150A film in Nichicon capacitors for AC-DC inverters: SABIC at PCIM Europe 1000
Feldspar inclusion dating of ceramics and burnt stones 1000
Digital and Social Media Marketing 600
Zeolites: From Fundamentals to Emerging Applications 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5987802
求助须知:如何正确求助?哪些是违规求助? 7407539
关于积分的说明 16048156
捐赠科研通 5128392
什么是DOI,文献DOI怎么找? 2751716
邀请新用户注册赠送积分活动 1722965
关于科研通互助平台的介绍 1627011